AnteoTech's AnteoBind™ Supports First-of-its-Kind COVID-19 Home Test     Labmate Online
Derek Thomson, Chief Executive Officer at AnteoTech. AnteoTech’s AnteoBind™ Supports First-of-its-Kind COVID-19 Home Test Feb 23 2021 Read 941 Times AnteoTech's long-term customer Ellume has secured a $231.8 million agreement with the U.S. Government to support accelerated manufacture of its COVID-19 home test. The test uses AnteoTech’s unique AnteoBind™ technology to support significantly improved sensitivity, and is the first rapid self-test for SARS-CoV-2 detection authorised by the United States Food and Drug Administration (FDA...